Agenus (AGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agenus (AGEN)

AGEN 3.965

-0.1%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: The Dodgy Ticker who wrote (6)	2/2/2004 8:34:22 PM
From: Area51	Read Replies (1) of 146

I agree there are some reasons to be bullish: If you look at the 1 yr analyst estimate the 1 yr target for AGEN is 19.12 which indicates a good return possibility, (http://finance.yahoo.com/q?s=agen). MLNM a stock I have more confidence in and a much larger position has a 1 yr target of about 19.27 (and I noticed you like it too). So AGEN has some potential. The analyst rating is good relative to other biotechs (small analyst coverage however: smartmoney.com But why the high short position? It seems the market shares tucks opinion that their Oncophage trial results are "underwhelming"? And more delay could open the door for competition from non patient specific formulations which the FDA is better geared to approve?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next